oxazoles has been researched along with Stomach Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bujak, A; Dymek, B; Dzwonek, K; Grygielewicz, P; Gunerka, P; Lamparska-Przybysz, M; Stanczak, A; Wieczorek, M; Zdzalik, D | 1 |
| Liu, Y; Lu, LP; Qin, XS; Tong, GH; Tong, WW | 1 |
| Ji, YB; You, QD; Zhou, JH; Zuo, MX | 1 |
| Fujiki, H; Suganuma, M | 1 |
| Byun, JY; Cha, MY; Choi, KJ; Jung, YH; Kang, SJ; Kim, MS; Lee, GS; Lee, HJ; Lee, KO; Park, SB; Song, JY | 1 |
| Kehraus, S; König, GM; Wright, AD | 1 |
| Hirakawa, K; Nakazawa, K; Tendo, M; Yamada, N; Yashiro, M | 1 |
| Hirakawa, K; Nakazawa, K; Ohira, M; Sawada, T; Tendo, M; Yamada, N; Yashiro, M | 1 |
| Hirakawa, K; Kosaka, K; Nakazawa, K; Shinto, O; Tendo, M; Yashiro, M | 1 |
| Chen, DD; Li, HL; Li, XH; Lü, JH; Ren, XD; Wang, CC; Zhang, HW | 1 |
| Chen, DD; Li, HL; Li, XH; Lu, YQ; Ren, XD; Ye, CL; Zhang, HW | 1 |
| Fujiki, H; Furuya, H; Matsunaga, S; Matsushima, R; Nishiwaki, S; Okabe, S; Suganuma, M; Sugimura, T; Yatsunami, J; Yoshizawa, S | 1 |
2 review(s) available for oxazoles and Stomach Neoplasms
| Article | Year |
|---|---|
Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors.
Topics: Animals; Carcinogens; Disease Progression; Enzyme Inhibitors; Humans; Marine Toxins; Mice; Models, Molecular; Neoplasms; Neoplasms, Experimental; Okadaic Acid; Oxazoles; Protein Phosphatase 1; Protein Phosphatase 2; Rats; Skin Neoplasms; Stomach Neoplasms; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2009 |
Specific mechanistic aspects of animal tumor promoters: the okadaic acid pathway.
Topics: Animals; Antifungal Agents; Carcinogens; Ethers, Cyclic; Liver Neoplasms; Marine Toxins; Mice; Molecular Structure; Okadaic Acid; Oxazoles; Peptides, Cyclic; Pyrans; Rats; Skin Neoplasms; Spiro Compounds; Stomach Neoplasms; Structure-Activity Relationship | 1992 |
10 other study(ies) available for oxazoles and Stomach Neoplasms
| Article | Year |
|---|---|
Epithelial-mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells.
Topics: Antineoplastic Agents; Benzamides; Cell Line, Tumor; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Humans; Isoxazoles; Molecular Targeted Therapy; Oxazoles; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Resorcinols; Stomach Neoplasms; Transforming Growth Factor beta1; Triazoles | 2016 |
DBD-F induces apoptosis in gastric cancer-derived cells through suppressing HIF2α expression.
Topics: Animals; Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Blotting, Western; Cell Line, Tumor; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Mice; Mice, Nude; Oxazoles; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms; Sulfonamides; Transfection; Xenograft Model Antitumor Assays | 2015 |
[Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oxazoles; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Topoisomerase I Inhibitors; Topotecan; Tumor Suppressor Protein p53 | 2008 |
Synthesis and biological evaluation of pyrimidine-based dual inhibitors of human epidermal growth factor receptor 1 (HER-1) and HER-2 tyrosine kinases.
Topics: Acrylamides; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Lapatinib; Lung Neoplasms; Mice; Mice, Inbred ICR; Models, Molecular; Mutation; Oxazoles; Pyrimidines; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, ErbB-2; Stomach Neoplasms; Structure-Activity Relationship | 2012 |
A new cytotoxic calyculinamide derivative, geometricin A, from the Australian sponge Luffariella geometrica.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Australia; Bacillus megaterium; Biphenyl Compounds; Chromatography, High Pressure Liquid; Drug Screening Assays, Antitumor; Escherichia coli; Eukaryota; Fungi; Furans; HIV Reverse Transcriptase; Humans; Indoles; Liver Neoplasms; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mass Spectrometry; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oxazoles; Porifera; Quinolizines; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Stereoisomerism; Stomach Neoplasms; Tumor Cells, Cultured | 2002 |
Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
Topics: Adenocarcinoma, Scirrhous; Animals; Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Fibroblasts; Fluorouracil; Hepatocyte Growth Factor; Humans; In Vitro Techniques; Mice; Mice, Nude; Oxazoles; Prostaglandins E; Stomach Neoplasms | 2005 |
A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells.
Topics: Adenocarcinoma, Scirrhous; Animals; Antimetabolites, Antineoplastic; Benzenesulfonates; Cyclooxygenase 2 Inhibitors; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Oxazoles; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Tumor Cells, Cultured | 2006 |
Selective cyclooxygenase-2 inhibitor downregulates the paracrine epithelial-mesenchymal interactions of growth in scirrhous gastric carcinoma.
Topics: Animals; Benzenesulfonates; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Epithelial Cells; Female; Fibroblast Growth Factor 7; Fibroblasts; Humans; Immunoblotting; Immunohistochemistry; Mesoderm; Mice; Mice, Inbred BALB C; Mice, Nude; Oxazoles; Paracrine Communication; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2007 |
JTE-522-induced apoptosis in human gastric adenocarcinoma [correction of adenocarcinoma] cell line AGS cells by caspase activation accompanying cytochrome C release, membrane translocation of Bax and loss of mitochondrial membrane potential.
Topics: Adenocarcinoma; Amino Acid Chloromethyl Ketones; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; bcl-2-Associated X Protein; Benzenesulfonates; Caspase Inhibitors; Caspases; Cyclooxygenase Inhibitors; Cysteine Proteinase Inhibitors; Cytochrome c Group; Enzyme Activation; Humans; In Situ Nick-End Labeling; Membrane Potentials; Mitochondria; Oxazoles; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Tumor Cells, Cultured | 2002 |
Changes of NF-kB, p53, Bcl-2 and caspase in apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: role of reactive oxygen species.
Topics: Adenocarcinoma; Apoptosis; Benzenesulfonates; Caspases; Cell Division; DNA-Binding Proteins; Humans; I-kappa B Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Oxazoles; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Stomach Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |